All In MedTech

Device Trial Radar · NCT06350864

HFNC Versus Conventional Oxygen Therapy in Prolonged Upper Gastrointestinal Endoscopy in the ICU

High-flow Nasal Cannula (HFNC) Oxygen Therapy Versus Conventional Nasal Oxygen Therapy (COT) in Prolonged Upper Gastrointestinal (UGI) Endoscopy Inside the Intensive Care Unit (ICU): a Prospective, Randomized, Controlled Clinical Study

Last checked: Nov 20, 2026Latest source record: Oct 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

70

Actual

Start

Apr 10, 2024

Primary completion

Sep 1, 2024

Study completion Sep 20, 2024

Sponsor

Lead sponsor
Ain Shams UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 5, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 20 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Conventional supplemental oxygen therapy (COT) during upper gastrointestinal (UGI) endoscopy via nasal catheter is considered the standard practice in maintenance of oxygenation and prevention of hypoxia. However, it is still unclear if this oxygen delivery method is optimal in a prolonged (more than 15 minutes) procedure in patients admitted to the ICU. Because of shortage of data in this concern, this prospective, randomized, controlled clinical trial study will aim to evaluate and compare the efficacy of high-flow nasal cannula (HFNC) oxygen therapy versus COT in patients who will undergo prolonged either diagnostic or therapeutic UGI endoscopy in the intensive care unit (ICU) .

Conditions

  • Upper Gastrointestinal Bleeding

Interventions

  • High-flow nasal cannula (HFNC)Device

    high flow cartridge and adult size nasal cannula: (flow range: 5-40L/minute, oxygen concentration (FiO2): 21-100%, temperature range: 33-39◦ C, humidity minimum of 12mg/liter)

  • Conventional nasal oxygen therapy (COT)Device

    Adult size, single use nasal cannula

  • Upper gastrointestinal endoscopy (UGE) including gastroscopyDevice

    Upper gastrointestinal endoscopy (UGE) will be either diagnostic and/or therapeutic including variceal band ligation, endoscopic hemostasis as injection of bleeding peptic ulcers with adrenaline or bleeders control via either argon plasma coagulation (APC) or heater probe coagulation.

  • Upper gastrointestinal endoscopy (UGE) including Endoscopic ultrasound (EUA)Device

    Upper gastrointestinal endoscopy (UGE) will be diagnostic

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Any occurrence of at least moderate hypoxemia of any duration measured by pulse oximetry during the procedure.Time frame: During the procedure.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ain Shams University-Faculty of Medicine

    Cairo, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.